Friday, November 14, 2014
Durham Drugmaker Ebola Dug Selected for Clinical Trials
Chimerix announced that the International Severe Acute Respiratory and Emerging Infection Consortium had selected its drug brincidofovir for clinical trials on Ebola patients in West Africa.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment